Social Synthesis Revenue and Competitors
Estimated Revenue & Valuation
- Social Synthesis's estimated annual revenue is currently $301.5k per year.
- Social Synthesis's estimated revenue per employee is $50,250
Employee Data
- Social Synthesis has 6 Employees.
- Social Synthesis grew their employee count by 50% last year.
Social Synthesis's People
| Name | Title | Email/Phone |
|---|
Social Synthesis Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $8M | 80 | 7% | N/A | N/A |
#2 | $8.8M | 88 | 9% | N/A | N/A |
#3 | $39.3M | 308 | -7% | $6.5M | N/A |
#4 | $15.7M | 142 | 18% | N/A | N/A |
#5 | $6.6M | 73 | -16% | N/A | N/A |
#6 | $39.2M | 312 | -7% | N/A | N/A |
#7 | $12.3M | 122 | 20% | N/A | N/A |
#8 | $7.9M | 79 | -4% | N/A | N/A |
#9 | $5.2M | 57 | 0% | N/A | N/A |
#10 | $21.4M | 194 | 5% | N/A | N/A |
What Is Social Synthesis?
We are an executive search firm. We support non-profit and social entrepreneurs to build their leadership team. Sajan@socialsynthedis.in
keywords:N/A
N/A
Total Funding
6
Number of Employees
$301.5k
Revenue (est)
50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Social Synthesis News
2022-04-20 - Asthma drug can block crucial SARS-CoV-2 protein: IISc study
This protein can bind to ribosomes -- the protein-making machinery -- inside our immune cells and shut down the synthesis of vital proteins...
2022-04-17 - Synthesis of evidence on the use of ecological momentary ...
Therefore, the ability to monitor physical, psychological, and social health outcomes after injury, along with experiences of service use,...
2022-03-30 - Social experiences switch states of memory engrams through ...
Social Reward Could Temporarily Switch the Silent Engram into the Latent State. We first tested whether SR could switch protein synthesis...
Other Companies in Mumbai
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.2M | 6 | N/A | N/A |
#2 | $0.2M | 6 | N/A | N/A |
#3 | $0.2M | 6 | N/A | N/A |
#4 | $0.3M | 6 | N/A | N/A |
#5 | $0.2M | 6 | N/A | N/A |